2004, Number 5
<< Back Next >>
Gac Med Mex 2004; 140 (5)
Usefulness of Establishing Diagnosis and Severity of the Most Frequent Signs and Symptoms in Preeclamptic Patients.
Peralta-Pedrero ML, Guzmán-Ibarra MA, Cruz-Avelar A, Basavilvazo-Rodríguez MA, Sánchez-Ambríz S, Martínez-García MC
Language: Spanish
References: 15
Page: 513-517
PDF size: 520.44 Kb.
ABSTRACT
Objective: Our aim was to determine that signs and symptoms
are tools in establishing diagnosis and severity of preeclampsia.
Materials and Methods: Our study design was prolective,
comparative, cross-sectional for evaluation of diagnosis.
Our sample included 408 patients. The study employed
classification criteria of the American College of Obstetricians
and Gynecologists.
One blinded family physician interrogated and examined each
patient. The sample included patients with recent diagnosis
and without treatment. Patients with HELLP syndrome,
eclampsia, and those in Intensive Care were excluded. Clinical
signs evaluated included headache, Phosphenes, acuphenes,
tinnitus, vomiting, epigastric pain, right hypochondrium pain,
ecchymosis, hematomas,and hyperreactive reflexes.
Results: A total of 192 patients without preeclampsia, 63 with
mild, and 153 with severe preeclampsia were included.
Clinical manifestations were absent in 60, 21 and 8% respectively
of patients in each group. Presence of three or more signs or
symptoms had sensitivity of 60% (CI95% 53-67), specificity of
84% (CI95% 79-89), and positive likelihood ratio of 3.8 and
negative, 0.48. Most usefulness data for diagnosis of
preeclampsia are hyperreactive reflexes, phosphenes,
acuphenes, right hypochondrium pain, and epigastric pain.
Conclusions: The symptoms and signs taken alone are tools
for evaluation of severity but not for detection of
preeclampsia. There is necessary to develop new way for
it’s diagnosis during prenatal care.
REFERENCES
Zhang I, Zeisler J, Hatch MC, Berkowitz G. Epidemiology of pregnancyinduced Hypertension. Epidemiol Rev 1997;19:218-232.
Estadísticas de mortalidad relacionada con la salud reproductiva. Salud Pública Mex 1999;41:138-146.
Helewa ME, Burrows RF, Smith J, Williams K, Brain P, Rabkin SW. Report of the Canadian Hypertension Society Consensus Conference:1. Definitions, evaluation and classification of hypertensive disorders in pregnancy. Can Med Assoc J 1997;157:715-725.
Sibai BM. Pitfalls in diagnosis and management of preeclampsia. Am J Obstet Gynecol 1988;159:1-5.
Report of the Nationall High Blood Pressure Education Program Working Group on High Blood Presure in Pregnancy. Am J Obstet Gynecol 2000;183(1):S-122.
ACOG technical bulletin. Hypertension in pregnancy. No. 219-january 1996 (remplaces no. 91, February 1988). Committee on Technical Bulletins of the American College of obstetricians and gynecologists. Int J Gynaecol obstet 1996;53:174-183.
Rolfes D, Ishak K. Liver Disease in Toxemia of Pregnancy. Am J Gastroenterol 1986;81:1138-1144.
Barry C, Fox R, Stirrat G. Upper abdominal pain in pregnancy may indicate preeclampsia. BMJ 1994;308:1562-1563.
Martin JN, May WL, Magann EF, Terrone DA, Rinehart B, Blake G. Early risk assessment of severe preeclampsia: Admission battery of symptoms and laboratory test to predict likelihood of subsequent significant maternal morbidity. Am J Obstet Gynecol 1999;180:1407-1414.
Villanueva EA, Alanis LP. Factores pronósticos asociados a la progresión de preeclampsia a eclampsia. Ginecología y Obstetricia de México 2000;67:312-316.
Dekker GA, Sibai BM. Primary, secondary, and tertiary prevention of preeclampsia. Lancet 2001;20:209-212.
Higgins JR, Swiet M. Blood-pressure measurement and classification in pregnancy. Lancet 2001;357:131-135.
Meyer NL, Mercer BM, Friedman SA, Sibai BM. Urinary dipstick protein: A poor predictor of absent or severe proteinuria 1994;170:137-141.
Cuningham J, MacDonald P, Gant NF, Leveno KS, Glistrap IILC, Hankins GD. Obstetricia. Médica Panamericana. México, 2a ed 1998.
Martin JN, Rinehart BK, May WL, Magann EF,Terrone DA, Blake PG. The spectrum of severe preeclampsia: Comparative analysis by HELLP (hemolysis, elevated liver enzyme levels, and low platelet count) syndrome classification. Am J Obstet Gynecol 1999;180:1373-1384.
Full text